Clinical Features of Liver Injury Induced by Immune Checkpoint Inhibitors in Japanese Patients

AIM: Immune checkpoint inhibitors (ICIs) have improved the survival rate of patients carrying various malignant neoplasms. Despite their efficacy, ICIs occasionally induce liver injury as an immune-related adverse event (irAE). This study aimed to reveal the clinical features of the hepatic irAE in...

Descripción completa

Detalles Bibliográficos
Autores principales: Imoto, Koji, Kohjima, Motoyuki, Hioki, Tomonobu, Kurashige, Tomoyuki, Kurokawa, Miho, Tashiro, Shigeki, Suzuki, Hideo, Kuwano, Akifumi, Tanaka, Masatake, Okada, Seiji, Kato, Masaki, Ogawa, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935806/
https://www.ncbi.nlm.nih.gov/pubmed/31929981
http://dx.doi.org/10.1155/2019/6391712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935806/
https://www.ncbi.nlm.nih.gov/pubmed/31929981
http://dx.doi.org/10.1155/2019/6391712

Ejemplares similares